Genmab — Juni 2017

[Bulder]

Ixazomib (Ninlaro) er en proteasomhæmmer, og som sådan ikke en direkte konkurrent til dara. Bliver snarere det, der skal overtage Velcades rolle.

[Sukkeralf]

Det er okay data men de kan ikke måle sig med Daratumumab - responsraten nogenlunde den samme, men Daratumumabs responser er dybere og holder længere (og det endda på mere syge patienter).

[Sukkeralf]

Ninlaro´s store fordel er den orale dosering

[E_L]

Takeda and Seattle Genetics Announce Positive Results from Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS (brentuximab vedotin) in Frontline Advanced Hodgkin Lymphoma -http://investor.seattlegenetics.com/phoenix.zhtml?c=124860&p=irol-newsArticle&ID=2282975

[JKY_VH]

Tak Bulder og Sukkeralf.

[Bulder]

Kyprolis og Ninlaro skal slås om retten til at kombinere med dara.

[E_L]

Alex Gorsky (CEO JNJ) on BBGtv, mentioning Darzalex first again, 'could have very material impact on JNJ earnings' 'we couldnt be more excited about this compound' and he talks about the ongoing investments they keep making in this compound

[Sukkeralf]

Nice words E L - thanks

[Solsen]

Didnt he say "we must own Genmab" ?

[Solsen]

Do you have any link EL

[Solsen]

They cant let 20% royalty run on many bn !

[E_L]

they have put the replay videos on : https://www.bloomberg.com/news/videos/2017-06-26/j-j-ceo-gorsky-on-m-a-health-care-tax-reform-video

[Solsen]

Thanks !!!

[digafarm]

The fun part begins at 3:20

[digafarm]

and thanks E L!

[Skyggen]

@digafarm Hvad sker der kl 03:20 vist noget jeg har misset

[JohnW]

Where does he say "we must own Genmab"?

[digafarm]

@skyggen jeg refererede til videoen E L lagde op kl. 15

[Skyggen]

Ahhhrrr ok, så forstår jeg tak digafarm
and thanks EL for the video it was sweet music

[Sukkeralf]

JohnW - nobody !! Solsen was just hoping'